Chávez LMÁ, Arvizu AJA, Espinosa HLE, González APM, Woog CA, Juárez TJC

Language: Spanish
References: 14
Page: 30-36
PDF size: 342.89 Kb.

ABSTRACT

Introduction: Adenomyosis is an entity in which the prevalence is very wide (5 to 70%), with a mean prevalence of 20 to 30%. Currently, the only confirmatory diagnosis is the histopathological study of the piece by hysterectomy, as well as the only way to study the real prevalence. In our environment, there are not many current studies that tell us the prevalence of this pathology, which is why it is important to carry out intentional searches. Objective: To estimate the prevalence of adenomyosis in patients undergoing total abdominal hysterectomy secondary to abnormal uterine bleeding. Material and methods: Cross-sectional, retrospective, descriptive study. This cross-sectional, retrospective, descriptive study was carried out in patients who underwent total abdominal hysterectomy due to abnormal uterine bleeding, collecting their histopathological reports from January 2017 to December 2019, patients with the presence of malignant lesions (cervical cancer, endometrial cancer) were excluded, which had an indication for hysterectomy due to pelvic organ prolapse, pelvic inflammatory disease, obstetric hemorrhage, with subtotal hysterectomy. Conclusions: A total of 168 patients were studied, in which a prevalence of 29.8% was observed, similar to that established in the general bibliography. No risk factors associated with this condition were found.

REFERENCES

1. Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018; 143 (3): 393-408.

2. Munro MG, Critchley HO, Broder MS, Fraser IS; FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011; 113 (1): 3-13.

3. Diagnóstico y tratamiento del sangrado uterino anormal de origen no anatómico. México: Instituto Mexicano del Seguro Social; 2015.

4. ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013; 121 (4): 891-896.

5. Benetti-Pinto CL, Rosa-E-Silva ACJS, Yela DA, Soares Júnior JM. Abnormal uterine bleeding. Rev Bras Ginecol Obstet. 2017; 39 (7): 358-368.

6. Cunningham RK, Horrow MM, Smith RJ, Springer J. Adenomyosis: a sonographic diagnosis. Radiographics. 2018; 38 (5): 1576-1589.

7. Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016; 23 (2): 164-185.

8. Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 68-81.

9. Nakayama H, Teramoto H, Teramoto M. True incidence of uterine adenomatoid tumors. Biomed Rep. 2013; 1 (3): 352-354.

10. Bacon JL. Abnormal uterine bleeding: current classification and clinical management. Obstet Gynecol Clin North Am. 2017; 44 (2): 179-193.

11. Arellano PEI, Labastida TJ. Prevalencia de adenomiosis en piezas quirúrgicas de histerectomía y factores de riesgo clínicos relacionados. Acta Med. 2018; 16 (1): 15-22.

12. Tan J, Yong P, Bedaiwy MA. A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis. Curr Opin Obstet Gynecol. 2019; 31 (4): 212-221.

13. Konrad J, Merck D, Wu JY, Tuomi A, Beland M. Improving ultrasound detection of uterine adenomyosis through computational texture analysis. Ultrasound Q. 2018; 34 (1): 29-31.

14. Bazot M, Darai E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018; 109 (3): 389-397.